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Summary
Background Insecticide-treated bednets (ITNs) are eﬀ ective in preventing malaria where vectors primarily bite indoors 
and late at night, but their eﬀ ectiveness is uncertain where vectors bite outdoors and earlier in the evening. We 
studied the eﬀ ectiveness of ITNs following a mass distribution in Haiti from May to September, 2012, where the 
Anopheles albimanus vector bites primarily outdoors and often when people are awake.
Methods In this case-control study, we enrolled febrile patients presenting to outpatient departments at 17 health 
facilities throughout Haiti from Sept 4, 2012, to Feb 27, 2014, who were tested with malaria rapid diagnostic 
tests (RDTs), and administered questionnaires on ITN use and other risk factors. Cases were deﬁ ned by positive RDT 
and controls were febrile patients from the same clinic with a negative RDT. Our primary analysis retrospectively 
matched cases and controls by age, sex, location, and date, and used conditional logistic regression on the matched 
sample. A sensitivity analysis used propensity scores to match patients on ITN use propensity and analyse malaria 
among ITN users and non-users. Additional ITN bioeﬃ  cacy and entomological data were collected. 
Findings We enrolled 9317 patients, including 378 (4%) RDT-positive cases. 1202 (13%) patients reported ITN use. 
Post-hoc matching of cases and controls yielded 362 cases and 1201 matched controls, 19% (333) of whom reported 
consistent campaign net use. After using propensity scores to match on consistent campaign ITN use, 2298 patients, 
including 138 (7%) RDT-positive cases, were included: 1149 consistent campaign ITN users and 1149 non-consistent 
campaign ITN users. Both analyses revealed that ITNs did not signiﬁ cantly protect against clinical malaria 
(odds ratio [OR]=0·95, 95% CI 0·68–1·32, p=0·745 for case-control analysis; OR=0·95, 95% CI 0·45–1·97, p=0·884 
for propensity score analysis). ITN and entomological data indicated good ITN physical integrity and bioeﬃ  cacy, and 
no permethrin resistance among local mosquitoes.
Interpretation We found no evidence that mass ITN campaigns reduce clinical malaria in this observational study in 
Haiti; alternative malaria control strategies should be prioritised.
Funding The Global Fund to Fight AIDS, Tuberculosis, and Malaria, and the US-based Centers for Disease Control 
and Prevention (CDC).
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license.
Introduction
Insecticide-treated bednets (ITNs) are a cornerstone of 
malaria prevention; multiple rigorous studies in 
sub-Saharan Africa have shown ITNs to be eﬀ ective in 
preventing malaria morbidity when used consistently.1–3 
ITNs take advantage of the indoor feeding (endophagic) 
and indoor resting (endophilic) behaviours of some 
Anopheles mosquitoes and work by repelling and killing 
or decreasing the life span of mosquitoes, as well as 
providing a physical barrier between mosquitoes and 
users.4,5 In Africa, the primary malaria vectors are from 
the Anopheles gambiae complex and the Anopheles funestus 
group, which predominantly bite indoors and when 
people are sleeping.6
Limited evidence exists on ITN eﬀ ectiveness in Latin 
America and the Caribbean. Anopheles albimanus, one of 
the dominant malaria vectors in Latin America,7 often 
bites outdoors (exophagic) and rests outdoors (exophilic).7 
Peak feeding times for A albimanus occur closer to sunset 
and generally earlier in the night than other 
Anopheles species,8–10 although there is substantial 
geographic heterogeneity.9 Findings from previous 
research on ITN eﬀ ectiveness with A albimanus have 
been mixed. In a Guatemalan study from the early 1990s,11 
both untreated and treated nets reduced incidence of 
malaria (by 47% and 57%, respectively) compared with 
the absence of nets. A 1992 Peruvian study12 found non-
signiﬁ cant reductions in malaria incidence after 
introduction of ITNs. Nicaraguan trials13 in 1996 reported 
that insecticide-treated materials signiﬁ cantly reduced 
community-level clinical malaria incidence, but only 
where community usage was greater than 16%.13 
Two studies14 from Ecuador from 1989–90 and from 
1991–92, respectively, found no signiﬁ cant diﬀ erence in 
malaria incidence after ITN introduction. A more recent 
observational study from Brazil, where the predominant 
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vector, Anopheles darlingi, is active throughout the day, 
found no eﬀ ect of ITNs after a mass distribution in 2012.15
Hispaniola is the only island in the Caribbean where 
malaria remains endemic, although at very low levels.16 
The vast majority of cases on the island are reported 
from Haiti (17 662 reported conﬁ rmed cases in 2013) 
compared with the Dominican Republic (496 cases 
in 2013).17 Plasmodium falciparum is the cause of nearly 
all malaria cases in Haiti,18,19 and the primary vector is 
A albimanus.
International attention and increased funding for 
rebuilding public health infrastructure in Haiti after 
the 2010 earthquake led to a renewed focus on malaria 
control and elimination.20 Before 2010, published data on 
malaria in Haiti were limited but indicated very low 
transmission, with one health facility survey21 in 1995 
estimating a slide-positivity rate of 4·0% among patients 
with suspected malaria; a population-based study22 in the 
rural Artibonite Valley in 2006 found a prevalence of 
3·1% by PCR. Post-earthquake studies from areas located 
near the epicentre of the earthquake conﬁ rmed high 
proportions of malaria infection among febrile patients 
attending clinics (46·9% and 20·3%),23,24 suggesting a 
potential increase in malaria, possibly because of 
improved surveillance or increased exposure to mosquito 
vectors after many people were left homeless.
As part of the national malaria control strategy and 
concern over a potential increase in malaria since the 
January, 2010, earthquake, a national campaign was 
conducted from May to September, 2012, to distribute 
ITNs (permethrin 2·0% treated, polyethylene 
monoﬁ lament) to all areas in Haiti, except in the capital 
Port-au-Prince, with a target of two ITNs per household. 
During the distribution, educational messages about 
ITN use were given along with pictorial brochures on 
how to use nets. Following this national ITN distribution, 
we did a case-control study to assess the eﬀ ectiveness of 
ITNs in Haiti for preventing clinical malaria.
Methods
Study setting, design, and sample size
In this case-control study, we recruited febrile patients 
presenting to outpatient departments at 17 health 
facilities in ﬁ ve departments in Haiti: Artibonite, Centre, 
Grand’Anse, Sud, and Sud-Est. We deﬁ ned cases as 
patients with history of fever or measured temperature 
of 37·5°C or higher and a positive malaria rapid 
diagnostic test [RDT]. We deﬁ ned controls as patients 
with a history of fever or measured temperature of 
37·5°C or higher and a negative malaria RDT. The study 
sample size was calculated to detect a 25% reduction in 
the odds of ITN use among malaria-positive patients 
compared with malaria-negative patients, assuming a 
two-sided α of 0·05, power of 0·80, an estimate of 30% 
controls exposed (ie, using ITNs), and a ratio of one case 
to three controls, resulting in 650 cases and 1950 controls 
required. Patients were not matched a priori on any 
factors, since no major imbalances were anticipated 
between cases and controls on relevant background 
variables, given the large sample size. Based on review of 
laboratory registers of conﬁ rmed malaria cases during 
the previous year, two health facilities in Sud-Est, 
Research in context
Evidence before this study
We searched PubMed for studies on bednet eﬀ ectiveness in 
settings outside of sub-Saharan Africa or with the 
Anopheles albimanus vector, using search terms including “ITN”, 
“bednet”, “LLIN”, “Anopheles albimanus”, and “Latin America” 
published between 1946 and 2016. Much of the available 
evidence on vector behaviour in Haiti is from older studies and 
describes a primarily exophagic (outdoor-biting) vector that 
can bite outside of sleeping hours. We found no previous 
studies on ITN eﬀ ectiveness in Haiti, and the evidence from 
other Latin American settings where A albimanus is the primary 
malaria vector was mixed, with some studies showing that 
ITNs are signiﬁ cantly protective and others showing no eﬀ ect.
Added value of this study
To our knowledge, this facility-based case-control study is the 
ﬁ rst study to assess the eﬀ ectiveness of ITNs in Haiti, following 
a 2012 mass campaign. We recruited febrile patients at 
17 health-care facilities and used two diﬀ erent analytical 
methods (retrospective matching and propensity score 
matching) to help ensure comparability between cases and 
controls. The study also collected ITN and entomological data, 
including ITN physical integrity and bioeﬃ  cacy at 
two timepoints as well as insecticide resistance, to aid in 
interpretation of results.
Implications of all the evidence
We found that consistent use of ITNs, following a mass 
distribution, does not appear to provide signiﬁ cant individual 
protection against clinical malaria in this case-control study in 
Haiti. ITN physical integrity and bioeﬃ  cacy performed well after 
12 and 18 months after the mass campaign, and mosquitoes 
were susceptible to permethrin, the insecticide used in the nets. 
The lack of ITN eﬀ ect could be explained by the vector’s 
predominantly exophagic behaviours and tendencies to bite 
before sleeping hours. Although it would be ideal to have a 
broader evidence base to guide vector control and malaria 
elimination decisions in Haiti, this case-control study provides 
the best evidence on mass ITN campaign eﬀ ectiveness to date, 
and additional studies on ITN eﬀ ectiveness are unlikely to be 
conducted in this low-transmission setting. Based on this 
study, wide-scale ITN distributions in Haiti are not 
recommended, and alternative strategies for malaria control 
should be prioritised. 
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a department reporting higher malaria test positivity, 
were initially selected for the study.
Patient recruitment began on Sept 4, 2012, at the two 
initial facilities. Because of low enrolment of cases, 
15 additional facilities in four departments (Artibonite, 
Centre, Grand Anse, and Sud) were added from April 29, 
2013, to Aug 3, 2013, bringing the total number of facilities 
to 17; thereafter, patient recruitment continued at the 
two initial sites and three facilities in Grand Anse with the 
highest case yield (ﬁ gure 1).
A community sensitisation campaign to increase 
health facility use for fever treatment was conducted 
during the study period.
Written informed consent was obtained from patients 
enrolling in the study. Patients younger than 18 years 
required consent from a parent or guardian; written 
assent was also obtained from patients aged 7–17 years. 
The study protocol was approved by the National 
Bioethics Committee of Haiti and the Institutional 
Review Board at the US Centers for Disease Control and 
Prevention (CDC) in Atlanta, GA, USA.
Procedures
Patients presenting to outpatient departments at study 
sites were systematically screened by study staﬀ  for fever 
(deﬁ ned as axillary temperature ≥37·5°C) or history of 
fever during the past 2 days. Eligible patients were given 
a brief questionnaire about their illness and previous 
treatment history, ownership and use of bednets, other 
malaria risk factors, knowledge of malaria, and 
household assets and characteristics. Finger prick 
samples of blood were taken for a malaria RDT and dried 
blood spots were also stored for PCR analysis. RDT 
results were read by study staﬀ  and given to clinicians to 
aid in case management at the facility.
To explore potential confounders to ITN eﬀ ective-
ness, we carried out a series of entomological and 
ITN assessments.
ITN physical integrity was assessed on a convenience 
sample of 30 ITNs from each department through visual 
inspection and categorisation of holes using the 
proportional hole index (PHI) developed by WHO.25 Up 
to 30 campaign ITNs from each department where the 
study was active at 12 and 18 months after distribution 
were collected, mounted on a frame in Port-au-Prince, 
and inspected.
Bioeﬃ  cacy of ITNs after 12 and 18 months was assessed 
at CDC in Atlanta (GA, USA) through cone bioassays25 on 
swatches cut from each side and the roof of collected nets. 
Five swatches per net were cut and 20 mosquitoes exposed 
to each swatch for a total of 100 mosquitoes exposed per 
net. Collected ITNs were replaced with new ITNs.
Insecticide content of ITNs was measured using 
gas chromatography on the sample of the same 
ITNs collected.25
Insecticide resistance testing was done for permethrin, 
using the CDC bottle bioassay26 on mosquitoes reared 
from ﬁ eld-collected larvae in each department where the 
study took place. Mosquitoes were exposed to 21·5 μg of 
permethrin per bottle for up to 120 min; control 
mosquitoes were ﬁ eld-reared mosquitoes exposed to 
acetone-impregnated bottles.
Pyrethrum spray catches25 were conducted in the 
two initial study sites to evaluate diﬀ erences in mosquito 
densities in homes with and without ITNs but very few 
Anopheles (only ten in total) were collected, possibly 
because of the timing of collections, which occurred later 
in the morning due to logistical constraints.
For the RDT diagnosis, CareStart (HRP2; AccessBio, 
Somerset, New Jersey, USA) P falciparum malaria RDTs 
were performed using ﬁ nger-prick blood and read in the 
ﬁ eld according to the manufacturer’s instructions, and 
results were communicated to patients and health facility 
clinicians. PCR analysis of ﬁ lter paper blood spots for 
RDT-positive patients and a sample of RDT-negative 
Figure 1: Map of study locations in Haiti (and timing of enrolment)
0 20 40 60 80 km
Nord-Ouest
Nord-Est
Centre
Ouest
Sud-Est
Nord
Artibonite
Nippes
Sud
Grande-Anse
Grande-Anse
Sources Chaudes
Jeremie
Seringue
Roseaux
Anse-Dhainault
Port-au-Prince
Department borders
Locations and sampling dates
September, 2012–February, 2014
April–August, 2013 and October, 2013–February, 2014
April–August, 2013
Unmatched Matched
Unexposed* Exposed Unexposed* Exposed
Consistent campaign ITN use before illness† 8115 1202 (12·9%) 1149 1149
Slept under campaign net the previous night 7987 1330 (14·3%) 1274 1274
Slept under any bednet the previous night 6135 3178 (34·1%) 2758 2758
Owns any bednet 3843 5474 (58·8%) 3039 3039
*Unexposed means no campaign net use or non-consistent campaign net use, not sleeping under campaign net the 
previous night, not sleeping under any bednet the previous night, and not owning a net. †Deﬁ ned as patient reporting 
sleeping under a campaign ITN “always” or 14 nights in the 2 weeks before illness onset.
Table 1: Various measures of bednet ownership and use in complete (n=9317) and propensity 
score-matched datasets
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patients and gas chromatography for chloroquine 
detection in 24 RDT-positive/PCR-negative samples were 
carried out in Atlanta (GA, USA) using standard 
laboratory methods (appendix).
Statistical analysis
ITNs were deﬁ ned as campaign ITNs if participants 
reported receiving them from the campaign and provided 
a date of receipt within 4 months of the campaign period. 
No other ITNs were widely available or distributed in 
Haiti before this time. The main predictor of interest was 
consistent use of campaign ITN, deﬁ ned as using a 
campaign ITN 14 out of 14 nights in the 2 weeks 
preceding illness onset. We also assessed alternative 
deﬁ nitions of bednet use, including use of a campaign 
ITN or any net the previous night. We deﬁ ned cases of 
clinical malaria as patients with a positive RDT. We 
compared samples with both RDT and PCR results to 
assess potential bias from low-density infections below 
the limit of detection for high-performing RDTs.
We retrospectively matched up to four controls per case, 
using exact matching on age group, sex, location (health 
facility and commune of residence), and date of 
presentation (within 14 days), and analysed the matched 
patients using conditional logistic regression.27 Each of the 
four matching variables was signiﬁ cantly related to the 
exposure (consistent campaign net use) and to the outcome 
(RDT positivity) and thus constituted an important 
confounder to match on (data not shown). Covariates were 
included in a multivariable model if their p value was 
below 0·20 in univariable analysis, and model selection 
was based on the lowest Akaike Information Criterion.28
As an alternative analytic approach to control for 
confounders related to bednet use, we used propensity 
scores, which can reduce bias in observational studies 
more eﬀ ectively than other statistical approaches.29 
We used logistic regression to estimate each patient’s 
propensity of consistent campaign ITN use. After 
restricting matches to the same geographical area (section 
communale), the lowest oﬃ  cial and standardly recognised 
administrative unit in Haiti, patients were matched 
one-to-one using nearest-neighbour matching with a 
caliper of 10%.30 Nearest neighbor matching resulted in 
good balance in the sample, with standardised diﬀ erences 
of less than 10% on all included variables31 (appendix). 
A logistic regression model was ﬁ t on the matched 
sample with clinical malaria as the outcome and 
consistent campaign net use as the predictor. Matching 
based on the other predictor variables—campaign ITN 
used last night, any net used last night, and ownership of 
any net—yielded larger matched datasets, as frequencies 
of these variables were higher (table 1).
We calculated standard descriptive statistics for ento-
mological and ITN integrity measures, and compared 
distributions of continuous variables using the Wilcoxon 
rank-sum test. All analyses were carried out using SAS 
version 9.3 (SAS Institute Inc, Cary, NC, USA).
Unmatched sample Matched sample
Negative 
RDT result 
(n=8939)
Positive 
RDT result 
(n=378)
Total 
(n=9137)
Negative 
RDT 
result 
(n=1201)
Positive 
RDT 
result 
n=362)
Total 
(n=1563)
Age
<5 years 3409 
(38·1%)
30 (7·9%) 3439 
(36·9%)
115 
(9·6%)
30 (8·3%) 145 
(9·3%)
5–9 years 1024 
(11·5%)
28 (7·4%) 1052 
(11·3%)
86 
(7·2%)
27 (7·5%) 113 
(7·3%)
10–19 years 1120 
(12·5%)
93 
(24·6%)
1213 
(13·0%)
227 
(18·9%)
81 
(22·4%)
308 
(19·7%)
≥20 years 3386 
(37·9%)
227 
(60·1%)
3613 
(38·8%)
773 
(64·4%)
224 
(61·9%)
997 
(63·8%)
Season
9/2012–2/2013 1137 
(12·7%)
167 
(44·2%)
1304 
(14·0%)
472 
(39·3%)
155 
(42·8%)
627 
(40·1%)
3/2013–4/2013 508 
(5·7%)
36 (9·5%) 544 
(5·8%)
138 
(11·5%)
36 
(9·9%)
174 
(11·1%)
5/2013–10/2013 5682 
(63·6%)
114 
(30·2%
5796 
(62·2%)
403 
(33·6%)
113 
(31·1%)
516 
(33·0%)
11/2013–2/2014 1612 
(18·0%)
61 
(16·1%)
1673 
(18·0%)
188 
(15·7%)
58 
(16·0%)
246 
(15·7%)
Male sex 3894 
(43·6%)
93 
(51·0%)
4087 
(43·9%)
644 
(46·4%)
182 
(49·7%)
826 
(47·2%)
Electricity at home 4430 
(49·6%)
181 
(48·0%)
4611 
(49·5%)
592 
(49·3%)
175 
(48·5%)
767 
(49·1%)
Asset ownership
Radio 5767 
(64·6%)
239 
(63·6%)
6006 
(64·5%)
771 
(64·2%)
234 
(65·0%)
1005 
(64·4%)
Television 2973 
(33·3%)
111 
(29·5%)
3084 
(33·1%)
352 
(29·3%)
108 
(30·0%)
460 
(29·5%)
Mobile phone 7492 
(83·9%)
324 
(85·9%)
7816 
(84·0%)
1031 
(85·9%)
309 
(85·6%)
1340 
(85·8%)
Owns any bednet 5253 
(58·8%)
223 
(58·5%)
1202 
(58·8%)
690 
(57·5%)
215 
(59·4%)
905 
(57·9%)
Campaign net use previous night 1247 
(14·0%)
83 
(22·0%)
1330 
(14·3%)
246 
(20·5%)
80 
(22·1%)
326 
(20·1%)
Consistent campaign net use 1132 
(12·7%)
70 
(18·5%)
1202 
(12·9%)
236 
(19·7%)
67 
(18·5%)
303 
(19·4%)
Use of indoor insect spray 
(eg, RAID, DOOM)
1446 
(16·2%)
36 (9·6%) 1482 
(15·9%)
157 
(13·1%)
33 (9·1%) 190 
(12·2%)
Knowledge that malaria is 
caused by mosquitos
7230 
(80·9%)
317 
(84·1%)
7547 
(81·1%)
1021 
(85·0%)
302 
(83·7%)
1323 
(84·7%)
Knowledge of ways to avoid 
malaria
7054 
(79·0%)
302 
(80·1%)
7356 
(79·0%)
968 
(80·6%)
289 
(80·0%)
1257 
(80·4%)
Education level of head of household
None 1998 
(24·7%)
117 
(34·7%)
2115 
(25·1%)
328 
(30·1%)
111 
(34·4%)
439 
(31·1%)
Primary 2782 
(34·4%)
127 
(37·7%)
2909 
(34·6%)
404 
(37·1%)
122 
(37·8%)
526 
(37·2%)
Secondary 2947 
(36·4%)
83 
(24·6%)
3030 
(36·0%)
321 
(29·5%)
82 
(25·4%)
403 
(28·5%)
Higher 354 
(4·4%)
9 (2·7%) 363 
(4·3%)
37 (3·4%) 8 (2·5%) 45 (3·2%)
Data are n (%). 
Table 2: Selected characteristics of unmatched and retrospectively matched samples
Articles
www.thelancet.com/lancetgh   Vol 5   January 2017 e100
Role of the funding source
CDC investigators were involved in study design, data 
analysis, interpretation, and preparation of the report.
Results
We recruited a total of 9317 patients with a valid RDT 
result, including 378 (4%) RDT-positive cases, across 
17 health facilities in ﬁ ve departments in Haiti.30 In the 
full sample, 1202 (13%) patients reported consistent 
campaign ITN use and 1330 (14%) reported sleeping 
under a campaign ITN the previous night (table 1). 
Post-hoc matching of cases and controls yielded 
362 cases and 1201 matched controls, 19% (333) of 
whom reported consistent campaign net use (table 2). 
Consistent campaign ITN use was not associated with 
clinical malaria in either univariable conditional logistic 
regression analysis (odds ratio [OR]=0·94, 95% CI 
0·68–1·31, p=0·614) or multivariable analysis (OR=0·95, 
0·68–1·32, p=0·745), adjusting for use of insect spray 
indoors and rudimentary rooﬁ ng material, the latter of 
which seemed to remain a risk factor for malaria 
(OR=1·78, 1·03–3·07, p=0·038; table 3). Variables 
indicating where patients spent the majority of their 
time between sunset and going to sleep (eg, indoors, 
outdoors) and for how much time they spent outside 
after sunset seemed to not be associated with clinical 
malaria (table 3). Multivariable conditional logistic 
regression models found no association between 
alternative deﬁ nitions of ownership or use of bednets 
and malaria (appendix).
After using propensity scores to match on consistent 
campaign ITN use, 2298 patients, including 138 (7%) 
RDT-positive cases, were included: 1149 consistent 
campaign ITN users and 1149 non-consistent campaign 
ITN users (table 1). Logistic regression on the propensity 
score-matched sample found no association between 
consistent campaign ITN use and clinical malaria 
(table 4). Alternative measures of bednet use, including 
sleeping under a campaign net or any net the previous 
night, were also not related to clinical malaria.
Among the 2695 samples with both RDT and PCR 
results, there was very good agreement between the 
two tests (κ=0·897), indicating that it was unlikely our 
study missed a large proportion of low-density malaria 
infections (table 5). The RDT-negative/PCR-positive 
samples were predominantly samples with low-density 
parasitaemia; of these 37 samples, 28 had an equivalent 
parasite density of less than 100 parasites per μL, based 
on PCR cycle time values, and two tested positive only for 
Plasmodium vivax by species-speciﬁ c nested rRNA PCR 
analysis. 21 (87%) of the 24 RDT-positive and PCR-negative 
samples were tested with gas chromatography, and 
nine (38%) of these indicated presence of chloroquine in 
the blood, supporting the hypothesis that some of this 
subset of patients had taken chloroquine before coming 
to the health facility. Only ﬁ ve of these nine patients 
reported previous chloroquine use during the health 
facility interview, and among all patients with RDT and 
PCR results, only 81 (3%) of 2693 reported chloroquine 
use before their facility visit.
Assessment of physical integrity, bioeﬃ  cacy, and 
insecticide content showed that campaign ITNs 
performed within WHO recommended standards. Using 
the proportional hole index cutoﬀ  of 300 (equivalent to a 
combined hole area of 1000 cm²) to deﬁ ne a failed net,32 
16% of sampled campaign ITNs were considered to be 
failed after 12 months and 13% (from two study sites) 
after 18 months (ﬁ gure 2).
Bioeﬃ  cacy testing using cone bioassays on campaign 
ITNs collected from all ﬁ ve study departments after 
12 months of use found an average of 97·9% mosquito 
knockdown after 60 min and mean 24-h mortality of 
Univariable models (n=1563) Multivariable model (n=1563)
Odds ratio 
(95% CI)
p value Adjusted odds ratio 
(95% CI)
p value
Consistent campaign net use 0·94 (0·68–1·31) 0·614 0·95 (0·68–1·32) 0·745
Rudimentary* rooﬁ ng material 1·83 (1·06–3·16) 0·029 1·78 (1·03–3·07) 0·038
Use of insect spray indoors 0·69 (0·46–1·03) 0·069 0·70 (0·46–1·05) 0·083
Has electricity 0·95 (0·73–1·23) 0·672 ·· ··
Sought care elsewhere before facility 0·67 (0·41–1·10) 0·113 ·· ··
Took antimalarial drugs before facility 0·97 (0·58–1·62) 0·903 ·· ··
Time spent outside after sunset, 
minutes
1·00 (1·00–1·00) 0·956 ·· ··
Knowledge that malaria caused by 
mosquitoes
0·67 (0·61–1·23) 0·413 ·· ··
Education level of respondent or caregiver
None (Reference) ·· ··
Primary 0·80 (0·44–1·47) 0·481 ·· ··
Some secondary 0·92 (0·66–1·27) 0·594 ·· ··
Completed secondary or higher 0·76 (0·43–1·36) 0·358 ·· ··
Univariable models are shown for predictors included in the multivariable model and for selected additional predictors. 
*Includes natural (thatched straw, leaves, or sod) or rudimentary (mat, wood planks) rooﬁ ng material, versus ﬁ nished 
material (metal, wood planks, tile, cement or concrete, shingles), as reported by patient or caregiver.
Table 3: Predictors of malaria from conditional logistic regression models using retrospective 
case-control matching 
Odds ratio (95% CI) p value
Consistent campaign net use before illness 0·95 (0·45–1·97) 0·884
Slept under campaign net last night 1·00 (0·83–1·21) 0·971
Slept under any bednet last night 1·17 (0·80–1·70) 0·423
Owns any bednet 1·21 (0·85–1·71) 0·286
Table 4: Odds ratios from propensity score-matched models of key 
bednet predictors on clinical malaria 
PCR negative 
(n=2350)
PCR positive 
(n=345)
Total 
(n=2695)
RDT negative 2326 37 2363
RDT positive 24 308 332
Table 5: Comparison of RDT and PCR results 
See Online for appendix
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72·1%, compliant with WHO-recommended functional 
ITN thresholds of either 95% knockdown or 
80% mortality (appendix);25 at 18 months, ITNs from two 
departments demonstrated 98·4% knock-down and 
68.3% mortality. Analysis of permethrin content 
indicated a mean of 26·5 g/kg (95% CI 26·2–26·8) 
among ITNs collected at baseline, mean of 23·8 g/kg 
(23·0–24·5) for 12-month nets, and mean of 15·8 g/kg 
(15·1–16·5) for 18-month-old ITNs, all within the 
WHO-speciﬁ ed range of 15–25 g/kg for permethrin; all 
nets at baseline and 12 months had permethrin content 
above 15 g/kg and 36 (77%) of 47 were above this 
minimum threshold at 18 months.
Lastly, to assess the presence of insecticide resistance 
in study areas, more than 700 mosquitoes reared from 
larvae collected in each of the ﬁ ve study departments 
underwent testing by CDC bottle bioassay. Results 
indicated no evidence of permethrin resistance, with 
mortality rates of 99–100% among mosquitoes exposed 
to permethrin and no mortality among control 
mosquitoes.
Discussion
We found no evidence that consistently used ITNs, 
following a mass distribution, reduced clinical malaria in 
this case-control study at 17 health facilities in 
ﬁ ve departments in Haiti. Bednet and entomological data 
indicated that nets were performing as intended, with 
good physical integrity, insecticide availability, and 
bioeﬃ  cacy after 12 and 18 months of use. Although there 
was some variability in mosquito mortality rates after 
exposure to nets collected from study participants across 
departments, knockdown measurements, rather than 
mortality, are typically used to assess eﬃ  cacy of 
permethrin-treated bednets, and these were consistently 
high across departments. No resistance of mosquitoes to 
permethrin was observed. Thus compromised ITN 
integrity, insecticide content, or vector resistance did not 
explain the lack of eﬀ ect. Reasons for the lack of 
association between ITN usage and malaria transmission 
in Haiti are not entirely clear and a single case-control 
study may not be deﬁ nitive. But one likely explanation 
for a lack of protective eﬀ ect may be vector behaviour. 
A albimanus in Haiti tends to bite outdoors and, at least 
in some locations, at times when people are not likely 
to be under nets.8,9,33,34 More broadly, the eﬀ ectiveness 
of ITNs against malaria in areas where A albimanus is 
the primary vector might depend on this vector’s 
predominant biting and resting locations (indoors vs 
outdoors) and preferred biting times. A study from areas 
of Nicaragua where A albimanus is dominant and 
primarily bites indoors and late at night, found that ITNs 
were eﬀ ective in reducing malaria in study clusters with 
rates of ITN use above 16%; however, a similar study in 
areas of Peru where A albimanus had greater outdoor and 
earlier biting rates found that ITNs did not signiﬁ cantly 
reduce malaria.12,13 An alternative explanation is that an 
eﬀ ect exists, but it was not detected by our study. Cases 
and controls were matched at the section communale 
level, but there is possibly heterogeneity in transmission 
within these administrative areas, which would weaken 
the power of the study.
In Haiti, studies in the north have suggested early 
outdoor biting,8,10 whereas a study in the south suggested 
later (middle-of-the-night) biting occurring equally 
indoors and outdoors.35 These ﬁ ndings might lead one to 
expect a more evident protective eﬀ ect of ITNs in the 
south, where most sites for this study were located, 
compared with the north; we nevertheless observed no 
such protective eﬀ ect of ITNs. More broadly, there is 
increasing recognition that vector control strategies in 
Latin America need to encompass methods that go 
beyond ITNs, especially in areas where A albimanus or 
other primarily exophagic vectors predominate.36
Our study indicated that indoor spraying with cans of 
non-residual insect sprays, which are primarily pyrethroid-
based, was protective (OR=0·70), although this eﬀ ect was 
only marginally signiﬁ cant in both univariable (p=0·069) 
and multivariable analyses (p=0·083). This ﬁ nding 
suggests that indoor biting potentially has a role in malaria 
transmission in Haiti, even if the vector is predominantly 
exophagic. It is possible that insecticides, including those 
used in indoor residual spraying that reduced malaria 
cases in the 1960s37 might be more eﬀ ective than ITNs, 
which presumably provide protection primarily during 
the later hours when household residents are sleeping 
under them. Even if a population of vectors is primarily 
Figure 2: Percentage of failed nets (total hole area >1000 cm²) and hole areas from bednet integrity 
evaluations at 12 and 18 months post-distribution
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exophilic, individual mosquitoes can still occasionally feed 
indoors, with concomitant exposure to insecticides. Thus, 
vector control interventions targeted indoors might still 
have some eﬀ ect in settings with exophagic vectors, but 
interventions, such as ITNs, that work only during times 
when people are asleep under them might be less eﬀ ective 
where the vector also bites earlier.
Our study also found rudimentary rooﬁ ng material to 
be a risk factor for clinical malaria. This ﬁ nding is 
consistent with other studies that have found that 
housing characteristics, including rooﬁ ng material, are a 
risk factor for malaria because more porous housing 
materials, including thatched roofs, open eaves and 
windows, provide more conducive places for mosquitoes 
to rest and enter homes than do less porous ones, 
including more modern housing materials, such as tile, 
cement, or tin roofs and closed eaves and windows.38
This study has several important limitations. The 
observational (non-experimental) case-control study 
design is not as strong for determining associations and 
causality as randomised trials, quasi-experimental designs, 
or other types of observational studies, such as cohort 
studies.39 However, randomised trials for interventions, 
such as ITNs, that have been shown to be eﬀ ective in other 
settings, and are included in a country’s national policy, 
would potentially raise ethical questions; more importantly, 
randomised trials, as well as cohort studies are not practical 
in low-transmission settings such as Haiti. Prospective 
cohort studies could provide stronger causal conclusions 
but are often impractical because large sample sizes are 
required for rare diseases. Case-control studies are 
appropriate for relatively rare diseases, such as malaria in 
very low-transmission settings like Haiti.27 Further, 
previous studies have successfully used case-control 
designs in Malawi and Afghanistan,40,41 and case-control 
designs have been recommended to assess ITN 
eﬀ ectiveness outside study settings.42 To mitigate bias, we 
attempted to control for measured potential confounders 
in two ways: using propensity score-matched samples and 
retrospectively matching cases and controls, with both 
methods showing very similar results across various 
deﬁ nitions of ITN use. Nonetheless, despite collecting data 
on a large number of covariates, an unmeasured 
confounder could be introducing bias into the estimates. 
Also, because the matching methods try to increase the 
interval validity of the study, possibly some bias is 
introduced as the external validity is diminished. 
Another limitation that has been raised about health 
facility-based case-control studies is attendance bias, 
whereby sick people at facilities might be more likely to 
come from households owning or using ITNs, thus 
underestimating the true eﬀ ectiveness of ITNs.43 This 
study took place following a universal ITN distribution 
campaign, probably minimising inequities in net 
ownership among households. Additionally, community 
health workers aﬃ  liated with study facilities conducted 
community sensitisation campaigns to increase 
case-seeking for fever at health facilities, where malaria 
treatment was free.
We did not achieve our target sample size, despite 
expanding from two facilities to 17, and extending the 
study time frame. This limitation illustrates the diﬃ  culty 
of conducting such studies in settings with very low and 
variable malaria transmission. However, ITNs were not 
signiﬁ cantly protective in our setting: the odds ratio for 
malaria with our primary exposure variable was close to 
one, along with the odds ratios from alternative 
deﬁ nitions of ITN use, including a sensitivity analysis we 
conducted of near-consistent users (12–14 of 14 nights 
prior to illness onset) versus non or infrequent users 
(0–2 of 14 nights), which should have maximised our 
likelihood of ﬁ nding an eﬀ ect.
Despite these limitations, this study provides the best 
available evidence on the eﬀ ectiveness of ITNs following 
the 2012 mass distribution campaign. The study strongly 
suggests that the campaign did not appear to be eﬀ ective 
for the prevention of clinical malaria and can help inform 
investments in malaria control as Haiti moves towards 
elimination. Other methods such as drug-based 
interventions to target the parasite reservoir, including 
targeted mass drug administration, which hold promise 
in low-transmission settings,44 in the context of enhanced 
surveillance and an eﬀ ective vector control strategy,45 as 
well as emerging strategies to address outdoor biting46 
might be more eﬀ ective. Widescale generalised 
community ITNs distribution was not supported by our 
ﬁ ndings. Given limited resources for malaria control in 
Haiti, alternative strategies should be prioritised.
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